Ultragenyx Pharmaceutical
Brittney McKittrick currently serves as the Director of Global Clinical Operations at Ultragenyx, focusing on Wilson Disease Gene Therapy since January 2021. Prior roles at Ultragenyx include Associate Director of Clinical Operations and Senior Clinical Project Manager, specifically in gene therapy for rare diseases. Previously, Brittney worked as a Clinical Trial Manager and Senior Clinical Research Associate at Finch Therapeutics Group and as a Clinical Research Coordinator at Regions Hospital, where various clinical trials were coordinated in diverse medical settings. Brittney's early career includes roles at Oregon Health and Science University, where responsibilities involved initiating and maintaining clinical trials, and at The Portland Clinic. Academically, Brittney holds a BA in Psychology from the University of Montana and is pursuing an MPM in Project Management at Colorado State University Global, with an expected completion in December 2025.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.